By: Kairos Ventures On: June 6, 2022 In: Linnaeus, Portfolio News

Linnaeus Therapeutics, Inc. announced the presentation of clinical data from its phase 1/2 clinical trial of LNS8801 in combination...

Read more

The University of Notre Dame Turbomachinery Laboratory (NDTL) completed construction of two new test cells dedicated to research, development and testing...

Read more
By: Kairos Ventures On: June 2, 2022 In: 3D Bio, Portfolio News

3DBio Therapeutics, a biotech company in Queens, said it had for the first time used 3-D printing to make...

Read more
By: Kairos Ventures On: June 2, 2022 In: 3D Bio, Portfolio News

3DBio and the Microtia-Congenital Ear Deformity Institute announced they have conducted a human ear reconstruction using the AuriNovo™ implant,...

Read more
By: Kairos Ventures On: May 24, 2022 In: Portfolio News, Provivi

Provivi is pleased to be featured at this year’s World Economic Forum in the DAVOS 2022 campaign. The meeting...

Read more
By: Kairos Ventures On: May 24, 2022 In: MemVerge, Portfolio News

Intesa Sanpaolo, Italy’s largest bank, is using Optane hardware with MemVerge and Hazelcast system software to enlarge the effective...

Read more
By: Kairos Ventures On: May 13, 2022 In: MemVerge, Portfolio News

MemVerge™ announced that SeekGene has significantly reduced processing time and cost for data intensive single-cell analysis tasks using MemVerge...

Read more
By: Kairos Ventures On: May 10, 2022 In: Portfolio News, Xidas

Sampling now, micro pressure sensors are the first in a series of the world’s most highly integrated microfluidic devices,...

Read more
By: Kairos Ventures On: May 9, 2022 In: MemVerge, Portfolio News

is the first to be recognized as a double Bio-IT World Award winner. It was recognized as the Bio-IT...

Read more
By: Kairos Ventures On: May 3, 2022 In: Foldax, Portfolio News

Foldax announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial...

Read more